 WALTHAM, Mass., Sept. 2, 2021 PRNewswire -- Syndax Pharmaceuticals, Inc. Syndax, the Company or we Nasdaq: SNDX, a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that members of its management team will participate in three upcoming virtual investor conferences: A fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference at 9:30 a.m. 